Curing Profound Autism and Psychiatric Disorders: The Promise of Stem Cells, Organoids, and Assembloids with Dr. Sergiu Pasca

The episode features Dr. Sergiu Pasca discussing autism, schizophrenia, and human brain development, focusing on the use of stem cells to create brain organoids and assembloids for studying and potentially curing severe psychiatric conditions. A central theme is the complexity of autism as a spectrum disorder, not a single disease, and the challenges in its diagnosis and treatment due to its behavioral definition and the brain's inaccessibility. Dr. Pasca highlights the significant increase in autism prevalence, now approaching 3% of the population, and the strong genetic component, contrasting it with earlier psychoanalytic theories like the "refrigerator mother hypothesis."

A crucial distinction is made between individuals with autistic traits who lead functional lives and those with "profound autism" who require lifelong care, often presenting with intellectual disability and epilepsy. Pasca emphasizes that autism is akin to "fever of the 19th century," a symptom with diverse underlying biological causes rather than a singular disease, which complicates treatment. He also addresses the higher prevalence in males (1:4 ratio), discussing potential factors like diagnostic masking in females and inherent differences in male and female brain development and resilience to injury. The discussion also touches on the lack of clear evidence for causal links between factors like the microbiome or dietary disturbances and autism, while acknowledging their potential impact on quality of life.

For families with a profound autism diagnosis, about 20% currently receive a genetic diagnosis, which, while informative (e.g., Timothy syndrome), does not yet translate into specific, targeted therapies. The hope is that understanding these genetic underpinnings will pave the way for individualized treatments. The episode implicitly suggests that while broad interventions like improving sleep or diet can enhance the well-being of individuals with autism, they are unlikely to address the core biological mechanisms. The primary practical insight from Dr. Pasca's work is the development of organoids and assembloids as powerful tools to overcome the "unbearable inaccessibility of the human brain," enabling direct study of disease mechanisms and drug development in a dish.

The broader implications extend to the future of psychiatric medicine, suggesting a paradigm shift from behaviorally defined disorders to biologically characterized conditions with molecular biomarkers. This approach, exemplified by the success in treating conditions like childhood leukemias once their biology was understood, offers a path forward for brain disorders. The discussion also contextualizes the challenges in understanding complex conditions, touching on historical correlative theories (e.g., maternal influenza and schizophrenia) and contemporary debates (e.g., vaccine-autism link, Amish populations), underscoring the need for rigorous biological investigation over anecdotal or correlative observations. The work with stem cells and brain models represents a frontier in neuroscience, promising not just treatments but fundamental insights into human brain wiring and development.

Dr. Pasca is one of a small handful of researchers that pioneered the discovery and development of what are called organoids and assembloids, which are essentially human brain circuits derived from stem cells that form in a dish so that one can study them directly.

Well, autism is a complex condition. It's a spectrum, as you said. In a way, you could say autism and neurodevelopmental disorders. It's behaviorally defined. There's no biomarker.

So, it was thought that it was resulting from having very cold parents, in particular a cold mother. It was the so-called refrigerator mother hypothesis of autism.

Another way of thinking about autism is that autism is not one disease. And I think, you know, no psychiatrist or even biologist who's studying autism would ever consider that this is one single disease.

We do know that some of them are very good at sort of what we call, like, masking the symptoms, or sort of like, learning the skills, social skills, and sort of like covering for that diagnosis.

But again, most of the evidence points out towards a very strong genetic component, behind it. And in fact, we now have hundreds of genes that we know when they are mutated, they are strongly associated with specific forms of autism.

And then the other one, which is certainly very important, which to a large extent is sort of like, you know, it's the source of all the work that we've done, is the unbearable inaccessibility of the human brain, so to speak.

And for the record, right now, there are no published papers that have not been retracted that support the vaccine-autism link.

So, about 20% of the patients will get a genetic diagnosis. Now sadly, that doesn't do that much today because we don't really have specific therapies for those forms.